Encompass Health Corporation revised earnings guidance for the year 2022. For the year, the company expects net operating revenue of $4,320 million to $4,350 million compared to pervious guidance of $4,250 million to $4,300 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
84.51 USD | +1.56% | +1.04% | +26.66% |
05-02 | Transcript : Encompass Health Corporation - Shareholder/Analyst Call | |
05-02 | Encompass Health Declares Dividend on Common Stock, Payable on July 15, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.66% | 8.38B | |
-15.68% | 16.57B | |
+4.50% | 12.51B | |
+4.48% | 11.69B | |
+6.18% | 10.36B | |
-2.66% | 7.75B | |
+20.39% | 7.12B | |
+3.42% | 6.6B | |
+46.01% | 4.54B | |
-6.40% | 4.2B |
- Stock Market
- Equities
- EHC Stock
- News Encompass Health Corporation
- Encompass Health Corporation Revises Earnings Guidance for the Year 2022